{"id":"CHEMBL1091250","canonicalSmiles":"O=C1/C(=C2\\Nc3ccc(S(=O)(=O)O)cc3C2=O)Nc2ccc(S(=O)(=O)O)cc21","inchiKey":"CFZXDJWFRVEWSR-BUHFOSPRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"INDIGOTINDISULFONATE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Indigotindisulfonate","NSC-8646"],"crossReferences":{"PubChem":["144206720","144206721"],"drugbank":["DB11577"],"chEBI":["90117"]},"childChemblIds":["CHEMBL2105023"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1091433","canonicalSmiles":"NN[14C](=O)c1ccncc1","inchiKey":"QRXWMOHMRWLFEY-ZQBYOMGUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"Pyridine-4-Carbohydrazide","maximumClinicalTrialPhase":0,"parentId":"CHEMBL64","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pyridine-4-Carbohydrazide"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1097279","canonicalSmiles":"CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@H](COP(=O)([O-])OP(=O)([O-])C(Cl)(Cl)P(=O)([O-])[O-])[C@@H](O)[C@H]1O.[Na+].[Na+].[Na+].[Na+]","inchiKey":"COWWROCHWNGJHQ-OPKBHZIBSA-J","drugType":"Small molecule","blackBoxWarning":false,"name":"CANGRELOR TETRASODIUM","yearOfFirstApproval":2015,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL334966","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Kengreal"],"synonyms":["AR-C69931MX","Cangrelor","Cangrelor tetrasodium","Cangrelor tetrasodium salt"],"count":2,"approvedIndications":["EFO_0000612","HP_0004419"],"linkedTargets":{"rows":["ENSG00000169313"],"count":1},"linkedDiseases":{"rows":["EFO_0008585","EFO_0000612","HP_0004419"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2015 and is indicated for recurrent thrombophlebitis and myocardial infarction."}
{"id":"CHEMBL109831","canonicalSmiles":"Nc1nc(=O)n([C@H]2C=C[C@@H](CO)O2)cc1F","inchiKey":"HSBKFSPNDWWPSL-CAHLUQPWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEXELVUCITABINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Reverset"],"synonyms":["DPC-817","Dexelvucitabine","INCB-8721","YZ-817"],"crossReferences":{"drugbank":["DB12470"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL113313","canonicalSmiles":"CN1N=C2CCN(C(=O)[C@@H](COCc3ccccc3)NC(=O)C(C)(C)N)C[C@@]2(Cc2ccccc2)C1=O","inchiKey":"KVLLHLWBPNCVNR-SKCUWOTOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CAPROMORELIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CP-424,391","CP-424391-18","Capromorelin","Cp-424,391","Cp-424391"],"crossReferences":{"Wikipedia":["Capromorelin"],"drugbank":["DB15205"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1141","canonicalSmiles":"[I-].[K+]","inchiKey":"NLKNQRATVPKPDG-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"POTASSIUM IODIDE","yearOfFirstApproval":1979,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Iosat","Jodetten depot","Kaliumjodid","Pot iodide ammoniat","Potassium iodide","Thyro-block","Thyrosafe","Thyroshield"],"synonyms":["NSC-77362","Potassium iodide"],"crossReferences":{"DailyMed":["potassium%20iodide"],"DrugCentral":["4296"],"Wikipedia":["Potassium_iodide"],"drugbank":["DB06715"],"chEBI":["8346"]},"count":6,"approvedIndications":["EFO_0003966","EFO_0004272"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1979 and is indicated for anemia (phenotype) and eye disease and has 4 investigational indications."}
{"id":"CHEMBL1159819","canonicalSmiles":"COc1ccc2c3c1O[C@H]1[C@@H](O)C=C[C@H]4[C@@H](C2)N(C)CC[C@]314.O=P(O)(O)O","inchiKey":"WUXLCJZUUHIXFY-FFHNEAJVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CODEINE PHOSPHATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL485","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1160597","canonicalSmiles":"Cc1cn([C@H]2C[C@H](N)[C@@H](COP(=O)(O)O)O2)c(=O)[nH]c1=O","inchiKey":"BQZMHQZNZNBJNF-XLPZGREQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1160597","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03233"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1173655","canonicalSmiles":"CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1","inchiKey":"ULXXDDBFHOBEHA-CWDCEQMOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AFATINIB","yearOfFirstApproval":2013,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Gilotrif","Giotrif"],"synonyms":["Afatinib","BIBW-2992","BIBW2992"],"crossReferences":{"DailyMed":["afatinib%20dimaleate"],"Wikipedia":["Afatinib"],"drugbank":["DB08916"],"chEBI":["61390"]},"childChemblIds":["CHEMBL2105712"],"count":26,"approvedIndications":["EFO_0000616","EFO_0000311"],"linkedTargets":{"rows":["ENSG00000146648","ENSG00000178568","ENSG00000141736"],"count":3},"linkedDiseases":{"rows":["EFO_0003869","EFO_0003859","EFO_0001065","MONDO_0021117","MONDO_0007254","EFO_0000708","HP_0000083","EFO_1001480","Orphanet_178","EFO_0009709","MONDO_0008903","MONDO_0001657","EFO_0000673","EFO_0000326","EFO_0000707","MONDO_0018352","EFO_0000616","EFO_0002618","EFO_0005922","EFO_1001956","EFO_0003060","EFO_0000311","EFO_0003863","EFO_0001421","EFO_0004284","EFO_0000702","EFO_0004142","EFO_0001378","MONDO_0024880","EFO_0000181","EFO_0000519"],"count":31},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2013 and is indicated for neoplasm and cancer and has 24 investigational indications."}
{"id":"CHEMBL1187","canonicalSmiles":"O=P(O)(O)O","inchiKey":"NBIIXXVUZAFLBC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHOSPHORIC ACID","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["E 338","E-338","E338","FEMA NO. 2900","INS NO.338","INS-338","NSC-80804","Phosphoric Acid","Phosphoric acid","Y-11A06"],"crossReferences":{"DailyMed":["phosphoric%20acid"],"PubChem":["144204604","144209483","144213563","17388778"],"Wikipedia":["Phosphoric_acid"],"drugbank":["DB09394"],"chEBI":["26078"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of IV and has 1 investigational indication."}
{"id":"CHEMBL1200338","canonicalSmiles":"CC(N/C(=N\\C#N)Nc1ccncc1)C(C)(C)C.O","inchiKey":"AFJCNBBHEVLGCZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PINACIDIL","yearOfFirstApproval":1989,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1159","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Pindac"],"synonyms":["Pinacidil","Pinacidil hydrate"],"crossReferences":{"PubChem":["144204505","170465261","56462991"],"Wikipedia":["Pinacidil"],"chEBI":["34923"]},"count":1,"approvedIndications":["EFO_0000537"],"linkedTargets":{"rows":["ENSG00000069431"],"count":1},"linkedDiseases":{"rows":["EFO_0000537"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1989 and is indicated for hypertension."}
{"id":"CHEMBL1200455","canonicalSmiles":"CC(=O)N(CC(O)CO)c1c(I)c(C(=O)NCC(O)CO)c(I)c(C(=O)NCC(O)CO)c1I","inchiKey":"NTHXOOBQLCIOLC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"IOHEXOL","yearOfFirstApproval":1985,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Exypaque","Omnipaque","Omnipaque 12","Omnipaque 140","Omnipaque 180","Omnipaque 210","Omnipaque 240","Omnipaque 300","Omnipaque 350","Omnipaque 70","Omnipaque 9","Oraltag"],"synonyms":["Iohexol","WIN 39424","WIN-39424"],"crossReferences":{"DailyMed":["iohexol"],"PubChem":["144205839","170464962","29217758","56322616"],"Wikipedia":["Iohexol"],"drugbank":["DB01362"],"chEBI":["31709"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1985 and has 3 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200604","canonicalSmiles":"CCN(Cc1ccncc1)C(=O)C(CO)c1ccccc1","inchiKey":"BGDKAVGWHJFAGW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TROPICAMIDE","yearOfFirstApproval":1960,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Mydriacyl","Mydriafair","Nods","Tropicacyl","Tropicamide"],"synonyms":["RO-1-7683","Tropicamide"],"crossReferences":{"DailyMed":["tropicamide"],"PubChem":["104171259","144203848","170464754","26747134","50086517","50104635","85231280","90341160"],"Wikipedia":["Tropicamide"],"drugbank":["DB00809"]},"count":3,"linkedTargets":{"rows":["ENSG00000133019"],"count":1},"linkedDiseases":{"rows":["EFO_0003966","EFO_0005758","EFO_0002508","HP_0000545","HP_0002307","EFO_1001158"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1960 and has 3 investigational indications."}
{"id":"CHEMBL1200607","canonicalSmiles":"FC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F","inchiKey":"ZJIJAJXFLBMLCK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PERFLEXANE","yearOfFirstApproval":2002,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["AF-0150","AF0150","Perflexane"],"crossReferences":{"PubChem":["144205881"],"drugbank":["DB09531"],"chEBI":["39427"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2002."}
{"id":"CHEMBL1200618","canonicalSmiles":"CC(C)(C(=O)O)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1.Cl","inchiKey":"RRJFVPUCXDGFJB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FEXOFENADINE HYDROCHLORIDE","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL914","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Allegra","Allegra allergy","Allegra hives","Children's allegra allergy","Children's allegra hives","Children's fexofenadine hydrochloride allergy","Children's fexofenadine hydrochloride hives","Fexofenadine hydrochloride","Fexofenadine hydrochloride allergy","Fexofenadine hydrochloride hives","Telfast 120","Telfast 180","Telfast 30"],"synonyms":["Fexofenadine hydrochloride","MDL 16,455A","MDL-16455A"],"crossReferences":{"DailyMed":["fexofenadine%20hydrochloride"],"PubChem":["144206676","170464669","26749923","26753303","50085984"]},"count":3,"approvedIndications":["EFO_0005854","EFO_0003956"],"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["EFO_0005854","EFO_1001417","EFO_0003956"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and is indicated for seasonal allergic rhinitis and allergic rhinitis and has 1 investigational indication."}
{"id":"CHEMBL1200902","canonicalSmiles":"CN1CCN(CC/C=C2/c3ccccc3Sc3ccc(S(=O)(=O)N(C)C)cc32)CC1.Cl","inchiKey":"ALDJVABCVUVJGI-SRJUEMFDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"THIOTHIXENE HYDROCHLORIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1201","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Navane","Thiothixene HCl","Thiothixene Hydrochloride Intensol"],"synonyms":["CP-12252-1"],"crossReferences":{"PubChem":["50107064"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1200981","canonicalSmiles":"COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@@H](O)[C@H](C)O1.Cl","inchiKey":"MWWSFMDVAYGXBV-FGBSZODSSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"EPIRUBICIN HYDROCHLORIDE","yearOfFirstApproval":1999,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL417","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ellence","Epirubicin hydrochloride","Farmorubicin","Pharmorubicin"],"synonyms":["Epirubicin hydrochloride","IMI-28","WP-697"],"crossReferences":{"DailyMed":["epirubicin%20hydrochloride"]},"count":33,"approvedIndications":["EFO_0000616","EFO_0003869","MONDO_0007254","EFO_0000305"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1999 and has 4 approved and 29 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201103","canonicalSmiles":"COc1ccc(OC)c(C(O)C(C)N)c1.Cl","inchiKey":"YGRFXPCHZBRUKP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHOXAMINE HYDROCHLORIDE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL524","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Vasoxine","Vasoxyl"],"synonyms":["Methoxamine hydrochloride"],"crossReferences":{"PubChem":["144204799","26747569","50106595","56422119","855753"]},"count":1,"linkedTargets":{"rows":["ENSG00000171873","ENSG00000170214","ENSG00000120907"],"count":3},"linkedDiseases":{"rows":["EFO_0009523"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982 and has 1 investigational indication."}
{"id":"CHEMBL1201201","canonicalSmiles":"CN[C@@H](C)Cc1ccccc1","inchiKey":"MYWUZJCMWCOHBA-VIFPVBQESA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"METHAMPHETAMINE","yearOfFirstApproval":1943,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"]},"tradeNames":[],"synonyms":["J6.362B","Metamfetamine","Methamphetamine","NSC-25115"],"crossReferences":{"DailyMed":["methamphetamine%20hydrochloride"],"Wikipedia":["Methamphetamine"],"drugbank":["DB01577"],"chEBI":["6809"]},"childChemblIds":["CHEMBL1200952"],"count":2,"approvedIndications":["EFO_0003888"],"linkedTargets":{"rows":["ENSG00000108576","ENSG00000103546","ENSG00000142319"],"count":3},"linkedDiseases":{"rows":["EFO_0003888","EFO_0004701"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1943 and is indicated for attention deficit hyperactivity disorder and has 1 investigational indication. It was withdrawn in United States. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201293","canonicalSmiles":"CC(=O)NCCCS(=O)(=O)O","inchiKey":"AFCGFAGUEYAMAO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ACAMPROSATE","yearOfFirstApproval":2004,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Acamprosate"],"crossReferences":{"DailyMed":["acamprosate%20calcium"],"PubChem":["50112716"],"Wikipedia":["Acamprosate"],"drugbank":["DB00659"],"chEBI":["51041"]},"childChemblIds":["CHEMBL2068724"],"count":12,"approvedIndications":["EFO_0003829"],"linkedTargets":{"rows":["ENSG00000183454","ENSG00000273079","ENSG00000116032","ENSG00000109158","ENSG00000145863","ENSG00000187730","ENSG00000011677","ENSG00000151834","ENSG00000145864","ENSG00000198785","ENSG00000166206","ENSG00000182256","ENSG00000161509","ENSG00000102287","ENSG00000022355","ENSG00000105464","ENSG00000094755","ENSG00000268089","ENSG00000163285","ENSG00000113327","ENSG00000176884","ENSG00000186297","ENSG00000163288"],"count":23},"linkedDiseases":{"rows":["EFO_0005203","EFO_0003756","HP_0000360","EFO_0002610","MONDO_0002009","HP_0000726","EFO_0003758","EFO_1001917","EFO_0003829","Orphanet_908","MONDO_0002046","EFO_1001892","EFO_0000289","MONDO_0002050","EFO_0004699","EFO_0004701","EFO_0005230","EFO_0000692","EFO_0005411"],"count":19},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2004 and is indicated for alcohol dependence and has 11 investigational indications."}
{"id":"CHEMBL1201346","canonicalSmiles":"O=C(O)CCNC(=O)c1ccc(/N=N/c2ccc(O)c(C(=O)O)c2)cc1","inchiKey":"IPOKCKJONYRRHP-FMQUCBEESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BALSALAZIDE","yearOfFirstApproval":2000,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Balsalazide"],"crossReferences":{"DailyMed":["balsalazide%20disodium"],"PubChem":["144205805","170465305","26758056"],"drugbank":["DB01014"],"chEBI":["267413"]},"childChemblIds":["CHEMBL1200760"],"linkedTargets":{"rows":["ENSG00000132170","ENSG00000073756","ENSG00000012779","ENSG00000095303"],"count":4},"linkedDiseases":{"rows":["EFO_0000729","HP_0004798"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2000."}
{"id":"CHEMBL1201577","drugType":"Antibody","blackBoxWarning":true,"name":"CETUXIMAB","yearOfFirstApproval":2004,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Erbitux"],"synonyms":["ABP-494","C-225","C225","CMAB-009","CMAB009","Cetuximab","Cetuximab (genetical recombination)","IMC-225","IMC-C225","MOAB C225"],"crossReferences":{"DailyMed":["cetuximab"],"DrugCentral":["4954"],"Wikipedia":["Cetuximab"]},"count":68,"approvedIndications":["EFO_0000616","EFO_0000365","EFO_0004142","EFO_0005842","EFO_1001951","EFO_0000311"],"linkedTargets":{"rows":["ENSG00000146648"],"count":1},"linkedDiseases":{"rows":["EFO_0003869","EFO_0003891","EFO_0000365","EFO_0000571","EFO_1000657","EFO_0000228","MONDO_0044704","EFO_1001951","MONDO_0002358","Orphanet_178","MONDO_0002974","MONDO_0008903","EFO_1000251","EFO_0000182","MONDO_0002038","MONDO_0018352","EFO_0002618","EFO_1001931","EFO_0005922","MONDO_0008170","EFO_0005842","MONDO_0008315","EFO_0005221","MONDO_0001879","EFO_0009708","EFO_1001967","MONDO_0002691","MONDO_0015917","EFO_0001061","MONDO_0044787","MONDO_0001023","EFO_1001100","EFO_0003868","EFO_0004284","EFO_0000233","EFO_0001378","EFO_0003835","MONDO_0021355","EFO_1000172","EFO_1001998","EFO_0002938","MONDO_0007254","EFO_0003871","EFO_0004252","MONDO_0021063","MONDO_0002087","EFO_0000231","MONDO_0001187","EFO_0003817","MONDO_0001056","EFO_1001480","EFO_1000044","MONDO_0021364","EFO_0009430","EFO_0006352","MONDO_0001657","EFO_0000673","EFO_0002499","EFO_0000707","EFO_0000616","EFO_0003897","EFO_0006859","EFO_0002916","EFO_0000503","EFO_0000478","EFO_0004198","EFO_0000313","MONDO_0007576","EFO_0007535","EFO_0003060","EFO_0000311","MONDO_0002529","MONDO_0011962","EFO_0004142","MONDO_0024880","EFO_0000691","EFO_0000181","EFO_0000519","EFO_1001950","MONDO_0044926"],"count":80},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2004 and has 6 approved and 62 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201595","drugType":"Enzyme","blackBoxWarning":true,"name":"LARONIDASE","yearOfFirstApproval":2003,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aldurazyme"],"synonyms":["A-l-iduronidase","Laronidase"],"crossReferences":{"DailyMed":["laronidase"],"DrugCentral":["4997"]},"count":4,"description":"Enzyme drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2003 and has 4 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201664","drugType":"Protein","blackBoxWarning":false,"name":"INSULIN ASPART PROTAMINE RECOMBINANT","yearOfFirstApproval":2001,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Insulin aspart protamine recombinant"],"crossReferences":{"DailyMed":["insulin%20aspart%20protamine%20recombinant"]},"linkedTargets":{"rows":["ENSG00000171105"],"count":1},"linkedDiseases":{"rows":["EFO_0001360"],"count":1},"description":"Protein drug with a maximum clinical trial phase of IV that was first approved in 2001."}
{"id":"CHEMBL1201824","drugType":"Enzyme","blackBoxWarning":true,"name":"ALGLUCOSIDASE ALFA","yearOfFirstApproval":2006,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Lumizyme","Myozyme"],"synonyms":["Acid .alpha.-glucosidase","Alglucosidase alfa","Alglucosidase alfa (genetical recombination)","GZ419829","RHGAA"],"crossReferences":{"DailyMed":["alglucosidase%20alfa"],"DrugCentral":["5030"]},"count":2,"approvedIndications":["Orphanet_365"],"description":"Enzyme drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2006 and is indicated for glycogen storage disease due to acid maltase deficiency and has 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1204146","canonicalSmiles":"Cc1ccc(N(CC2=NCCN2)c2cccc(O)c2)cc1.Cl","inchiKey":"TUEJFGFQYKDAPM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENTOLAMINE HYDROCHLORIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL597","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Regitine hydrochloride"],"synonyms":["Phentolamine hydrochloride"],"crossReferences":{"PubChem":["26748359","26748360","50107382","50107383","56422183","855923"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1207745","canonicalSmiles":"CC#CCC(C)[C@H](O)/C=C/[C@@H]1[C@H]2c3cccc(CCCC(=O)O)c3O[C@H]2C[C@H]1O","inchiKey":"CTPOHARTNNSRSR-APJZLKAGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BERAPROST","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Beraprost","MDL-201229","ML-1229","TRK-100STP FREE ACID"],"childChemblIds":["CHEMBL435883"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1230961","canonicalSmiles":"CN[C@@H]1[C@@H](O[C@H]2O[C@H](CO)[C@@H](N)[C@H](O)[C@H]2O)O[C@H]2C[C@@H](N)[C@@H](O[C@@H]3[C@@H](N)C[C@@H](N)[C@H](O)[C@H]3O)O[C@@H]2[C@@H]1O","inchiKey":"XZNUGFQTQHRASN-XQENGBIVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"Apramycin","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Apramycin"],"crossReferences":{"PubChem":["144204190"],"Wikipedia":["Apramycin"],"drugbank":["DB04626"],"chEBI":["2790"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1232445","canonicalSmiles":"C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1C[C@@H](O)[C@H]2O","inchiKey":"PROQIPRRNZUXQM-PNVOZDDCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"17-Epiestriol","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["17-Epiestriol"],"crossReferences":{"drugbank":["DB07702"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1232583","canonicalSmiles":"COc1ccc(S(=O)(=O)n2cc(CCC(=O)O)c3cc(OC)ccc32)cc1","inchiKey":"YMPALHOKRBVHOJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"INDEGLITAZAR","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Indeglitazar","PPM-204"],"crossReferences":{"drugbank":["DB07724"]},"count":1,"linkedTargets":{"rows":["ENSG00000112033","ENSG00000186951","ENSG00000132170"],"count":3},"linkedDiseases":{"rows":["EFO_0000400"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1232673","canonicalSmiles":"NS(=O)(=O)c1ccc(F)cc1","inchiKey":"LFLSATHZMYYIAQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"4-Fluorobenzenesulfonamide","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["4-Fluorobenzenesulfonamide"],"crossReferences":{"drugbank":["DB01784"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1232973","canonicalSmiles":"O=C(O)c1nsnc1O","inchiKey":"FVZITYNLUYJDOE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1232973","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03162"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1234270","canonicalSmiles":"Nc1nc(=O)c2c([nH]1)NC[C@@H]1CN(c3ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc3)CN21","inchiKey":"QYNUQALWYRSVHF-OLZOCXBDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ARFOLITIXORIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Modufolin"],"synonyms":["Arfolitixorin","ISO-901","Modufolin","[6R]-5,10-methylenetetrahydrofolate ([6R]-5,10- MTHF)"],"crossReferences":{"drugbank":["DB12676"],"chEBI":["1989"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1234781","canonicalSmiles":"O=C(O)COc1cccc2ccccc12","inchiKey":"GHRYSOFWKRRLMI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NAPHTHYLOXYACETIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["14739759"],"drugbank":["DB08286"],"chEBI":["44588"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1236068","canonicalSmiles":"CNC(=O)[C@@H](C)[C@H]1C(=O)/C(=C(O)/C=C/C(C)=C/[C@@H](C)[C@H]2O[C@@]3(C)O[C@H](C=C[C@@]34CO4)[C@@H]2C)C(=O)N1[C@@H]1CC[C@H](O)[C@H](C)O1","inchiKey":"KVTPRMVXYZKLIG-NCAOFHFGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"STREPTOLYDIGIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"Wikipedia":["Streptolydigin"],"drugbank":["DB04785"],"chEBI":["45773"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1236682","canonicalSmiles":"COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(C[C@H](O)CO)CC1","inchiKey":"RDSACQWTXKSHJT-NSHDSACASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"REFAMETINIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BAY 869766","BAY 8697661","BAY-86-9766","BAY-869766","BAY-8697661","BAY86-9766","Bay-86-9766","RDEA 119","RDEA-119","Refametinib"],"crossReferences":{"drugbank":["DB06309"]},"count":4,"linkedTargets":{"rows":["ENSG00000126934","ENSG00000169032"],"count":2},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0003060","EFO_0000182","EFO_0000311"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL123678","canonicalSmiles":"CCOc1cc2ncnc(Nc3cccc(-c4csc(CO)n4)c3)c2cc1OCC","inchiKey":"ZJESXGUODSBHSK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL123678","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02848"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1289","canonicalSmiles":"Clc1cc(Cl)c(OCC#CI)cc1Cl","inchiKey":"CTETYYAZBPJBHE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HALOPROGIN","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Halotex","Mycanden"],"synonyms":["Haloprogin","M-1028"],"crossReferences":{"PubChem":["144206294","225144320","50125846"],"Wikipedia":["Haloprogin"],"drugbank":["DB00793"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL12948","canonicalSmiles":"CC1CCC(NC(=O)N(CCCl)N=O)CC1","inchiKey":"FVLVBPDQNARYJU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SEMUSTINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ICIG 1110","ICIG-1110","METHYL-CCNU","Semustine"],"crossReferences":{"PubChem":["144204957","26748800","46500621"],"chEBI":["6863"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL13","canonicalSmiles":"COCCc1ccc(OCC(O)CNC(C)C)cc1","inchiKey":"IUBSYMUCCVWXPE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"METOPROLOL","yearOfFirstApproval":1978,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["CGP-2175","Lopressidone","Metoprolol","Toprol-XL"],"crossReferences":{"DailyMed":["metoprolol%20succinate","metoprolol%20tartrate"],"PubChem":["251919670"],"Wikipedia":["Metoprolol"],"drugbank":["DB00264"],"chEBI":["6904"]},"childChemblIds":["CHEMBL1200337","CHEMBL1200840","CHEMBL2062335","CHEMBL545787","CHEMBL3186768","CHEMBL2356097","CHEMBL3989566","CHEMBL1868892"],"count":23,"approvedIndications":["EFO_0000319"],"linkedTargets":{"rows":["ENSG00000043591"],"count":1},"linkedDiseases":{"rows":["EFO_0003777","EFO_0000275","EFO_0000318","EFO_0004278","EFO_0005252","MONDO_0007254","Orphanet_848","EFO_0000373","EFO_0000274","EFO_0000538","EFO_0000266","EFO_0009094","EFO_0007148","EFO_0003913","EFO_0003914","EFO_0003911","Orphanet_739","EFO_0008585","EFO_0003144","EFO_0005306","EFO_0000676","EFO_1002032","EFO_0003917","EFO_0009321","EFO_0000407","EFO_0008586","HP_0001653","EFO_0000616","HP_0003124","EFO_0004269","EFO_0001645","EFO_1001466","EFO_0000319","MONDO_0024361","EFO_0001073","EFO_0000537","EFO_0000195","Orphanet_79292","EFO_1000391","EFO_0001068","EFO_0004287","EFO_0000764","HP_0004308","EFO_0008583","EFO_0000612","EFO_0000341","EFO_0001360","HP_0012594","EFO_0005672"],"count":49},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1978 and is indicated for cardiovascular disease and has 22 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1306","canonicalSmiles":"CC(C)N1CCN(c2ccc(OC[C@H]3CO[C@](Cn4cncn4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1","inchiKey":"BLSQLHNBWJLIBQ-OZXSUGGESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TERCONAZOLE","yearOfFirstApproval":1987,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Fungistat","Gyno-Terazol","Panlomyc","Terazol","Terazol 3","Terazol 7","Terconazole","Triaconazole"],"synonyms":["NSC-331942","R 42470","R-42,470","R-42470","Terconazole","Triaconazole"],"crossReferences":{"DailyMed":["terconazole"],"PubChem":["144204230","56463234"],"Wikipedia":["Terconazole"],"drugbank":["DB00251"],"chEBI":["82980"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1987 and has 2 investigational indications."}
{"id":"CHEMBL1377","canonicalSmiles":"CC(C)NC(=N)NC(=N)Nc1ccc(Cl)cc1","inchiKey":"SSOLNOMRVKKSON-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHLOROGUANIDE","yearOfFirstApproval":2000,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Chlorguanide","Chloroguanide","Proguanil"],"crossReferences":{"DailyMed":["proguanil%20hydrochloride"],"PubChem":["11112433","174006624"],"Wikipedia":["Proguanil"],"drugbank":["DB01131"],"chEBI":["8455"]},"childChemblIds":["CHEMBL1201059"],"count":2,"approvedIndications":["EFO_0001068"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2000 and is indicated for malaria and has 1 investigational indication."}
{"id":"CHEMBL142464","canonicalSmiles":"CCNCCCNC/C=C\\CNCCCNCC","inchiKey":"XFWLTFZLLXVKDY-WAYWQWQTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CGC-11047","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CGC-11047","Cgc-11047","SL 11047","SL 47"],"childChemblIds":["CHEMBL3104344","CHEMBL4296681"],"count":3,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1561","canonicalSmiles":"OCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO","inchiKey":"IBAQFPQHRJAVAV-ULAWRXDQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MIGLITOL","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Diastabol","Glyset","Miglitol"],"synonyms":["BAY M 1099","BAY-M-1099","Miglitol"],"crossReferences":{"DailyMed":["miglitol"],"PubChem":["144204989","170465326","26719889","49681630"],"Wikipedia":["Miglitol"],"drugbank":["DB00491"],"chEBI":["6935"]},"count":3,"approvedIndications":["EFO_0001360","EFO_0000400"],"linkedTargets":{"rows":["ENSG00000257335","ENSG00000171298"],"count":2},"linkedDiseases":{"rows":["EFO_0001359","EFO_0001360","EFO_0000400"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and is indicated for diabetes mellitus and type ii diabetes mellitus and has 1 investigational indication."}
{"id":"CHEMBL157138","canonicalSmiles":"CCN(CC)C(=O)N[C@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1","inchiKey":"BKRGVLQUQGGVSM-KBXCAEBGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LISURIDE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Revanil 200"],"synonyms":["Lisuride","Lisuride maleate","Lysuride"],"crossReferences":{"Wikipedia":["Lisuride"],"drugbank":["DB00589"],"chEBI":["51164"]},"childChemblIds":["CHEMBL1257128"],"count":4,"approvedIndications":["EFO_0003821"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for migraine disorder and has 3 investigational indications."}
{"id":"CHEMBL160038","canonicalSmiles":"O=C(Cc1ccccc1)c1cc(O)c(O)c([N+](=O)[O-])c1","inchiKey":"MRFOLGFFTUGAEB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NEBICAPONE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Nebicapone"],"crossReferences":{"drugbank":["DB14849"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1611","canonicalSmiles":"O=C1N=C([O-])NC1(c1ccccc1)c1ccccc1.[Na+]","inchiKey":"FJPYVLNWWICYDW-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":true,"name":"PHENYTOIN SODIUM","yearOfFirstApproval":1956,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL16","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dilantin","Diphenylan sodium","Extended phenytoin sodium","Pentran","Phenytek","Phenytex","Phenytoin sodium","Prompt phenytoin sodium"],"synonyms":["Diphenylhydantoin sodium","Phenytoin Sodium","Phenytoin sodium","Phenytoin sodium for injection","Phenytoin sodium salt"],"crossReferences":{"DailyMed":["phenytoin%20sodium"],"PubChem":["11112021","144212655","14742085","26757853","50106089","85231301","855788"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1956. This drug has a black box warning from the FDA."}
{"id":"CHEMBL162036","canonicalSmiles":"CC(=O)Nc1ccc(OC(=O)c2ccccc2OC(C)=O)cc1","inchiKey":"FEJKLNWAOXSSNR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BENORILATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Benoral","Triadol"],"synonyms":["Benorilate","Benorylate","Fenasprate","WIN 11450"],"crossReferences":{"PubChem":["144206025","170466237","50112722"],"Wikipedia":["Benorilate"],"drugbank":["DB13657"]},"count":2,"approvedIndications":["HP_0001945","EFO_0003843"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for pain and fever."}
{"id":"CHEMBL1632","canonicalSmiles":"CC(=O)OCC1=C(C(=O)[O-])N2C(=O)[C@@H](NC(=O)Cc3cccs3)[C@H]2SC1.[Na+]","inchiKey":"VUFGUVLLDPOSBC-XRZFDKQNSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"CEPHALOTHIN SODIUM","yearOfFirstApproval":1974,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL617","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Averon","Cefalotin","Cephalothin","Cephalothin sodium","Keflin","Seffin","Synclotin","Toricelocin"],"synonyms":["38253","Cefalotin sodium","Cephalothin sodium"],"crossReferences":{"PubChem":["50106038","855938"],"chEBI":["3542"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1974."}
{"id":"CHEMBL16332","canonicalSmiles":"C[C@H](CS)C(=O)N1C[C@@H](Sc2ccccc2)C[C@H]1C(=O)O","inchiKey":"UQWLOWFDKAFKAP-WXHSDQCUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ZOFENOPRILAT","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Zofenoprilat"],"crossReferences":{"Wikipedia":["Zofenoprilat"],"drugbank":["DB08766"],"chEBI":["82602"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1644695","canonicalSmiles":"[I-].[Na+]","inchiKey":"FVAUCKIRQBBSSJ-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"SODIUM IODIDE","yearOfFirstApproval":1976,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["NSC-77388","Sodium iodide"],"crossReferences":{"DailyMed":["sodium%20iodide%20i-123","sodium%20iodide%20i-131"],"PubChem":["144211696"],"Wikipedia":["Sodium_iodide"],"drugbank":["DB11119"],"chEBI":["33167"]},"childChemblIds":["CHEMBL1201083","CHEMBL3707217","CHEMBL1201084","CHEMBL2105877"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1976 and has 1 investigational indication."}
{"id":"CHEMBL1655","canonicalSmiles":"CN(C)CCOc1ccc(/C(=C(/CCCl)c2ccccc2)c2ccccc2)cc1","inchiKey":"XFCLJVABOIYOMF-QPLCGJKRSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"TOREMIFENE","yearOfFirstApproval":1997,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["GTX-006","J33.157K","Toremifene"],"crossReferences":{"DailyMed":["toremifene%20citrate"],"PubChem":["29216214"],"Wikipedia":["Toremifene"],"drugbank":["DB00539"],"chEBI":["9635"]},"childChemblIds":["CHEMBL1200675"],"count":10,"approvedIndications":["EFO_0000616"],"linkedTargets":{"rows":["ENSG00000091831","ENSG00000140009"],"count":2},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0007608","EFO_0003869","MONDO_0004658","MONDO_0008170","EFO_0009907","MONDO_0007254","EFO_0002621","EFO_0003882","EFO_0000305","MONDO_0008315","EFO_0003931","MONDO_0100096","EFO_1001366"],"count":14},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1997 and is indicated for neoplasm and has 9 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1684590","canonicalSmiles":"C[C@@H]1[C@H]2C3=CC[C@@H]4[C@@]5(C)C[C@@H](O)[C@H](O)[C@@](C)(CO)[C@@H]5CC[C@@]4(C)[C@]3(C)CC[C@@]2(C(=O)O[C@@H]2O[C@H](CO[C@@H]3O[C@H](CO)[C@@H](O[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@H](O)[C@H]3O)[C@@H](O)[C@H](O)[C@H]2O)CC[C@H]1C","inchiKey":"WYQVAPGDARQUBT-FGWHUCSPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1684590","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB14081"],"chEBI":["79928"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1697768","canonicalSmiles":"O=S(=O)([O-])Oc1ccc(C(c2ccc(OS(=O)(=O)[O-])cc2)c2ccccn2)cc1.[Na+].[Na+]","inchiKey":"GOZDTZWAMGHLDY-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"SODIUM PICOSULFATE","yearOfFirstApproval":2012,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1741134","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Citrafleet","Dulcolax pico","Otc concepts","Picolax"],"synonyms":["DA 1773","DA-1773","LA 391","LA-391","Picosulfate sodium","Sodium picosulfate","Sodium picosulfate hydrate"],"crossReferences":{"DailyMed":["sodium%20picosulfate"],"DrugCentral":["4779"],"PubChem":["144206577"],"chEBI":["32147"]},"count":1,"approvedIndications":["HP_0002019"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2012 and is indicated for constipation."}
{"id":"CHEMBL1697782","canonicalSmiles":"CCC(=O)O[C@]1(C(=O)COC(C)=O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C","inchiKey":"DALKLAYLIPSCQL-YPYQNWSCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHYLPREDNISOLONE ACEPONATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Advantan"],"synonyms":["Methylprednisolone aceponate"],"crossReferences":{"drugbank":["DB14643"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL1697829","canonicalSmiles":"O=C(Cn1cnnn1)N[C@@H]1C(=O)N2C(C(=O)O)=C(CSc3nncs3)CS[C@H]12","inchiKey":"DZMVCVMFETWNIU-LDYMZIIASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFTEZOLE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ceftezole","Ceftezole sodium"],"crossReferences":{"drugbank":["DB13821"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1742994","drugType":"Antibody","blackBoxWarning":true,"name":"BRENTUXIMAB VEDOTIN","yearOfFirstApproval":2011,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Adcetris"],"synonyms":["Brentuximab vedotin","CAC10-VCMMAE","SGN-35"],"crossReferences":{"DailyMed":["brentuximab%20vedotin"],"DrugCentral":["4964"]},"count":26,"approvedIndications":["MONDO_0009348","EFO_0000616","EFO_0003032","EFO_0000183"],"linkedTargets":{"rows":["ENSG00000261456","ENSG00000120949","ENSG00000104833","ENSG00000188229","ENSG00000137267","ENSG00000258947","ENSG00000101162","ENSG00000196230","ENSG00000137285","ENSG00000176014"],"count":10},"linkedDiseases":{"rows":["MONDO_0009348","EFO_0000616","MONDO_0013730","EFO_0004708","MONDO_0019471","EFO_0001642","EFO_0002913","EFO_0000403","EFO_0000222","EFO_0005952","EFO_0004599","EFO_0000211","EFO_0000565","EFO_0000404","EFO_0003032","EFO_0000096","EFO_0002690","EFO_0000095","EFO_0000588","EFO_0007359","EFO_0000574","EFO_1001051","EFO_0000514","EFO_0000183","MONDO_0018906","MONDO_0019473","EFO_1000785"],"count":27},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2011 and has 4 approved and 22 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1743073","drugType":"Protein","blackBoxWarning":false,"name":"SOTATERCEPT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ACE-001","ACE-011","Sotatercept"],"count":7,"linkedTargets":{"rows":["ENSG00000122641"],"count":1},"linkedDiseases":{"rows":["EFO_0001361","MONDO_0044903","Orphanet_231222","EFO_0004272","EFO_0001378","Orphanet_231214","EFO_1000388","HP_0012410"],"count":8},"description":"Protein drug with a maximum clinical trial phase of II (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL1749","canonicalSmiles":"O=C([O-])CN(CCN(CC(=O)[O-])CC(=O)O)CC(=O)O.[Na+].[Na+]","inchiKey":"ZGTMUACCHSMWAC-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"EDETATE DISODIUM","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Disodium Edetate","Edetate Disodium","Endrate","Sodium Versenate"],"synonyms":["Disodium edetate dihydrate","Disodium edetate hydrate","E386","Edetate Disodium","Edta disodium salt","Edta disodium salt anhydrous","NSC-2760","Sodium Edetate"],"crossReferences":{"DrugCentral":["4708"],"drugbank":["DB14600"],"chEBI":["64734"]},"childChemblIds":["CHEMBL3989507"],"count":4,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1982 and has 4 investigational indications."}
{"id":"CHEMBL178657","canonicalSmiles":"CCN(CC)S(=O)(=O)c1cc(C(=O)Nc2ccccc2C(=O)O)ccc1Br","inchiKey":"VNOMZKMKBNFCMC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL178657","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07429"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1801594","canonicalSmiles":"[11CH3]c1ccc(-c2cc(C(F)(F)F)nn2-c2ccc(S(N)(=O)=O)cc2)cc1","inchiKey":"RZEKVGVHFLEQIL-BJUDXGSMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1801594","maximumClinicalTrialPhase":0,"parentId":"CHEMBL118","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL189558","canonicalSmiles":"O=C1N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@H]1Cc1ccc(O)cc1","inchiKey":"NGPCLOGFGKJCBP-HOTGVXAUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"Cyclo(-Trp-Tyr)","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cyclo(-Trp-Tyr)"],"crossReferences":{"drugbank":["DB08761"],"chEBI":["65063"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1950289","canonicalSmiles":"O[C@H]1CC[C@H](Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@H]4CCOC4)c3n2)CC1","inchiKey":"IBGLGMOPHJQDJB-IHRRRGAJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TANZISERTIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CC-930","JNK 930","JNK-930","Tanzisertib"],"crossReferences":{"drugbank":["DB11798"]},"count":1,"linkedTargets":{"rows":["ENSG00000107643","ENSG00000050748","ENSG00000109339"],"count":3},"linkedDiseases":{"rows":["EFO_0000768","MONDO_0004670"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL19612","canonicalSmiles":"NCCCCNCCCN","inchiKey":"ATHGHQPFGPMSJY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SPERMIDINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Spermidine"],"crossReferences":{"PubChem":["11111787","11113819","124881418","90340561"],"Wikipedia":["Spermidine"],"drugbank":["DB03566"],"chEBI":["16610"]},"childChemblIds":["CHEMBL1256356","CHEMBL1473196"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL204543","canonicalSmiles":"Oc1ccc2ccccc2c1O","inchiKey":"NXPPAOGUKPJVDI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"Naphthalene-1,2-Diol","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Naphthalene-1,2-Diol"],"crossReferences":{"drugbank":["DB07610"],"chEBI":["17435"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL206031","canonicalSmiles":"Cc1nc(COc2ccc(C[C@H](NC(=O)O[C@H]3CO[C@H]4OCC[C@@H]34)[C@H](O)CN(CC(C)C)S(=O)(=O)c3ccc4c(c3)OCO4)cc2)cs1","inchiKey":"JORVRJNILJXMMG-OLNQLETPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BRECANAVIR","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Brecanavir","GW-640385","GW-640385X","GW-64085X","GW640385","GW64085X"],"crossReferences":{"Wikipedia":["Brecanavir"],"drugbank":["DB04887"]},"childChemblIds":["CHEMBL2377051","CHEMBL2377050"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2103844","canonicalSmiles":"NCCNc1ccc(NCCN)c2c1C(=O)c1ccncc1C2=O.O=C(O)/C=C\\C(=O)O.O=C(O)/C=C\\C(=O)O","inchiKey":"SVAGFBGXEWPNJC-SPIKMXEPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PIXANTRONE DIMALEATE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL167731","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BBR 2778","BBR 2778 DIMALEATE","BBR-2778 DIMALEATE","Pixantrone dimaleate","Pixantrone dimaleate salt","Pixantrone maleate"],"count":3,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2103845","canonicalSmiles":"CN(C)CCO/N=C(/C=C/c1ccc(O)cc1)c1ccccc1F.CN(C)CCO/N=C(/C=C/c1ccc(O)cc1)c1ccccc1F.O=C(O)/C=C/C(=O)O","inchiKey":"RNLKLYQQDLHHBH-ABDBJYMXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EPLIVANSERIN FUMARATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL257704","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Eplivanserin fumarate","SR46349B"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2104292","canonicalSmiles":"C#CCC1(OC(N)=O)CCCCC1","inchiKey":"MIRHIEAGDGUXKL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HEXAPROPYMATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Hexapropymate"],"crossReferences":{"drugbank":["DB13662"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2104519","canonicalSmiles":"Cc1cc(O)c(C2CC3CCC2(C)C3(C)C)cc1C","inchiKey":"RNRHMQWZFJXKLZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"XIBORNOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Xibornol"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2105420","canonicalSmiles":"O=S1(=O)CCN(CN2CCS(=O)(=O)NC2)CN1","inchiKey":"AJKIRUJIDFJUKJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TAUROLIDINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Taurolidine","W-3100M"],"crossReferences":{"drugbank":["DB12473"]},"count":5,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL2105618","canonicalSmiles":"C=CC[C@]1(O)CC[C@H]2[C@@H]3CCC4=CCCCC4[C@H]3CC[C@@]21C","inchiKey":"ATXHVCQZZJYMCF-XZCODKSBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALLYLESTRENOL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Gestanin"],"synonyms":["Allylestrenol","Allyloestrenol"],"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL2105654","canonicalSmiles":"Clc1cc(N2C[C@@H]3CN[C@@H]3C2)cnc1Cl.O=S(=O)(O)c1ccccc1","inchiKey":"QDWNBBFBKYGQFG-RDNZEXAOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SOFINICLINE BENZENESULFONATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL238465","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["A-422894.112","Sofinicline benzenesulfonate"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2105664","canonicalSmiles":"CC(OC(=O)c1ccc(Cc2c(O)c3ccccc3oc2=O)cc1)(C(F)(F)F)C(F)(F)F","inchiKey":"QFLNTQDOVCLQKW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TECARFARIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ATI-5923","Tecarfarin"],"crossReferences":{"drugbank":["DB12823"]},"childChemblIds":["CHEMBL2105676"],"description":"Small molecule drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL2105711","canonicalSmiles":"CCc1ccc(Cc2ccc3c(c2)[C@]2(OC3)O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)cc1.O","inchiKey":"ZXOCGDDVNPDRIW-NHFZGCSJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TOFOGLIFLOZIN","maximumClinicalTrialPhase":3,"parentId":"CHEMBL2110731","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CSG 452","CSG-452","CSG452","R-7201","RO-4998452","RO4998452","Tofogliflozin","Tofogliflozin hydrate","Tofogliflozin monohydrate"],"crossReferences":{"Wikipedia":["Tofogliflozin"]},"count":1,"linkedTargets":{"rows":["ENSG00000140675"],"count":1},"linkedDiseases":{"rows":["EFO_0003095","EFO_0001360"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2106953","canonicalSmiles":"CN1C(C(=O)Nc2ccccn2)=C(O)c2ccccc2S1(=O)=O.NCCO","inchiKey":"FVTSYHPRVGNAQI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PIROXICAM OLAMINE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL527","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CP-16,171-85","Piroxicam olamine"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2107299","canonicalSmiles":"Cl.O=C(O)c1cccc(-c2cccc(NCCNC[C@H](O)c3cccc(Cl)c3)c2)c1","inchiKey":"PMXCGBVBIRYFPR-FTBISJDPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SOLABEGRON HYDROCHLORIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL208427","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GW427353B","Solabegron hydrochloride"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2107301","canonicalSmiles":"CC(C)[C@H](N)C(=O)OCC[C@@H](CO)Cn1cnc2c(=O)[nH]c(N)nc21","inchiKey":"ATSZELKUSAREPW-ZJUUUORDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VALOMACICLOVIR","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["EPB-348","Valomaciclovir"],"crossReferences":{"drugbank":["DB06575"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2107373","canonicalSmiles":"Cc1nc2c(N)nc3cccnc3c2n1CC(C)C","inchiKey":"ZXBCLVSLRUWISJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SOTIRIMOD","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["R-850","S-30594","Sotirimod"],"crossReferences":{"drugbank":["DB05680"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2107384","canonicalSmiles":"COC[C@@H](c1ccc(C(F)(F)F)cc1)N1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)C[C@@H]1C.O=C(O)/C=C\\C(=O)O","inchiKey":"GXINKQQWHLIBJA-UCIBKFKQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VICRIVIROC MALEATE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL82301","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MK-4176","SCH 417690","SCH-417690","Sch417690","Vicriviroc maleate"],"count":1,"linkedTargets":{"rows":["ENSG00000160791"],"count":1},"linkedDiseases":{"rows":["EFO_0000764"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2107781","canonicalSmiles":"O=C([O-])[C@H](O)[C@@H](O)C(=O)[O-].[Na+].[Na+]","inchiKey":"HELHAJAZNSDZJO-OLXYHTOASA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"SODIUM TARTRATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Sodium tartrate"],"crossReferences":{"DrugCentral":["4780"],"drugbank":["DB13707"],"chEBI":["63017"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2108688","drugType":"Unknown","blackBoxWarning":false,"name":"SMALLPOX VACCINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Smallpox vaccine"],"count":2,"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2108707","drugType":"Antibody","blackBoxWarning":false,"name":"GLEMBATUMUMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CR-011","CR011","CR011-VCMMAE","Glembatumumab"],"count":2,"linkedTargets":{"rows":["ENSG00000136235"],"count":1},"linkedDiseases":{"rows":["EFO_0000756","MONDO_0007254"],"count":2},"description":"Antibody drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2109050","drugType":"Unknown","blackBoxWarning":false,"name":"LAUROMACROGOL 400","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Lauromacrogol","Lauromacrogol 400","Polyoxyl 9 lauryl ether"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2109128","drugType":"Protein","blackBoxWarning":false,"name":"LENOGRASTIM","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Granocyte-13","Granocyte-34"],"synonyms":["Granulocyte colony-stimulating factor lenograstim","Lenograstim","Lenograstim (genetical recombination)","RG-CSF"],"crossReferences":{"DrugCentral":["5167"]},"count":4,"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL2109193","drugType":"Antibody","blackBoxWarning":false,"name":"GAVILIMOMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ABX-CBL","Gavilimomab"],"count":1,"linkedTargets":{"rows":["ENSG00000172270"],"count":1},"linkedDiseases":{"rows":["MONDO_0013730"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2109328","drugType":"Antibody","blackBoxWarning":false,"name":"IMC-EB10","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["IMC-EB10","Imc-eb10"],"count":1,"linkedTargets":{"rows":["ENSG00000122025"],"count":1},"linkedDiseases":{"rows":["MONDO_0004643"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2109338","drugType":"Antibody","blackBoxWarning":false,"name":"AMG-729","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AMG-729"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2109455","drugType":"Antibody","blackBoxWarning":false,"name":"AL-901","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AL-901"],"description":"Antibody drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2109553","drugType":"Antibody","blackBoxWarning":false,"name":"CYT-500 177LU","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CYT-500","Cyt-500 177lu"],"count":1,"linkedTargets":{"rows":["ENSG00000086205"],"count":1},"linkedDiseases":{"rows":["EFO_0000196"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2110666","canonicalSmiles":"N#C[C@@H]1C[C@H](F)CN1C(=O)[C@@H](N)C(c1ccc(F)cc1)c1ccc(F)cc1","inchiKey":"URRAHSMDPCMOTH-LNLFQRSKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DENAGLIPTIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Denagliptin"],"childChemblIds":["CHEMBL2104962"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2178422","canonicalSmiles":"N[C@@H]1c2cccnc2[C@H](OC(=O)N2CCC(n3c(=O)[nH]c4ncccc43)CC2)CC[C@H]1c1cccc(F)c1F","inchiKey":"KRNAOFGYEFKHPB-ANJVHQHFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RIMEGEPANT","yearOfFirstApproval":2020,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["BMS-927711","Rimegepant"],"crossReferences":{"DailyMed":["rimegepant%20sulfate"],"drugbank":["DB12457"]},"childChemblIds":["CHEMBL2364629"],"count":2,"linkedTargets":{"rows":["ENSG00000064989"],"count":1},"linkedDiseases":{"rows":["EFO_1001219","EFO_0003821","EFO_0000676"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2020 and has 2 investigational indications."}
{"id":"CHEMBL2180408","canonicalSmiles":"COCCc1ccc(-c2c(C)nc3c(N4CCOCC4)ccnn23)cn1","inchiKey":"BPLVDYJDAVYLRQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"JNJ-42396302","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Jnj-42396302"],"crossReferences":{"drugbank":["DB12657"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2218913","canonicalSmiles":"C[C@@H]1NC(=O)[C@@H](N)CNC(=O)[C@H](C2CCNC(=N)N2)NC(=O)/C(=C/NC(N)=O)NC(=O)[C@H](CNC(=O)CC(N)CCCN)NC1=O.N=C1NCCC([C@@H]2NC(=O)/C(=C/NC(N)=O)NC(=O)[C@H](CNC(=O)CC(N)CCCN)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CNC2=O)N1.O=S(=O)(O)O.O=S(=O)(O)O","inchiKey":"TUATYNXRYJTQTQ-BVRBKCERSA-N","drugType":"Protein","blackBoxWarning":true,"name":"CAPREOMYCIN SULFATE","yearOfFirstApproval":1971,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL2221250","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Capastat sulfate"],"synonyms":["34977","Capreomycin sulfate"],"crossReferences":{"DailyMed":["capreomycin%20sulfate"]},"description":"Protein drug with a maximum clinical trial phase of IV that was first approved in 1971. This drug has a black box warning from the FDA."}
{"id":"CHEMBL222287","canonicalSmiles":"CC[C@H]1C[C@H]2C[C@H]3c4[nH]c5ccc(OC)cc5c4CCN(C2)[C@@H]13","inchiKey":"HSIBGVUMFOSJPD-NXWOVTFFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IBOGAINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["10-Methoxyibogamine","Ibogaine","NSC-249764"],"crossReferences":{"chEBI":["5852"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL227875","canonicalSmiles":"O=[N+]([O-])c1cn2c(n1)OC[C@@H](OCc1ccc(OC(F)(F)F)cc1)C2","inchiKey":"ZLHZLMOSPGACSZ-NSHDSACASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PRETOMANID","yearOfFirstApproval":2019,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["PA 824","PA-824","PA824","Pretomanid"],"crossReferences":{"DailyMed":["pretomanid"],"Wikipedia":["PA_824"],"drugbank":["DB05154"]},"count":4,"approvedIndications":["EFO_1000049"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2019 and is indicated for pulmonary tuberculosis and has 3 investigational indications."}
{"id":"CHEMBL2303617","canonicalSmiles":"C1CCN2C[C@H]3C[C@H](CN4CCCC[C@H]34)[C@@H]2C1.O.O.O.O.O.O=S(=O)(O)O","inchiKey":"WNSDDGBLIALDPB-HTZKOJAYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SPARTEINE SULFATE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL412873","hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"]},"tradeNames":[],"synonyms":["Sparteine Sulfate","Sparteine sulfate"],"description":"Small molecule drug with a maximum clinical trial phase of IV. It was withdrawn in United States."}
{"id":"CHEMBL232148","canonicalSmiles":"NS(=O)(=O)c1ccc(-c2ccc(/C=C3\\SC(=O)NC3=O)o2)cc1","inchiKey":"JNPRTUHVCHGFHJ-GHXNOFRVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL232148","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["50085448"],"drugbank":["DB07531"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL235668","canonicalSmiles":"N=C1CCCN1Cc1nc(O)nc(O)c1Cl","inchiKey":"QQHMKNYGKVVGCZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TIPIRACIL","yearOfFirstApproval":2015,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["MA-1","TPI (freebase)","Tipiracil"],"crossReferences":{"DailyMed":["tipiracil%20hydrochloride"],"drugbank":["DB09343"]},"childChemblIds":["CHEMBL65375"],"count":3,"linkedTargets":{"rows":["ENSG00000025708"],"count":1},"linkedDiseases":{"rows":["EFO_1001480","EFO_0003869","EFO_0000365","EFO_1000657","EFO_0004142","MONDO_0007254","MONDO_0044937","EFO_0005221","EFO_1001951"],"count":9},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2015 and has 3 investigational indications."}
{"id":"CHEMBL2359044","canonicalSmiles":"CN1CCCC(CC2c3ccccc3Sc3ccccc32)C1.Cl","inchiKey":"RSXZRFHNNTTWCB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL2359044","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1201342","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144204061","170465287"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2361370","canonicalSmiles":"CC(C)(C)NC[C@H](O)COc1ccccc1C1CCCC1.CC(C)(C)NC[C@H](O)COc1ccccc1C1CCCC1.O=S(=O)(O)O","inchiKey":"FEDSNBHHWZEYTP-ZFQYHYQMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PENBUTOLOL SULFATE","yearOfFirstApproval":1987,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1290","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Betapressin","Levatol"],"synonyms":["HOE 39-893D","HOE 893D","Penbutolol sulfate"],"crossReferences":{"PubChem":["144204192"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1987."}
{"id":"CHEMBL236345","canonicalSmiles":"Cn1cc(NC(=O)c2cc(NC(=O)c3ccc(/C=C/c4cnc5ccccc5c4)cc3)cn2C)cc1C(=O)NCCN1CCOCC1","inchiKey":"OEKXCVYZBVOWBR-BQYQJAHWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MGB-BP-3","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["J2.725.402K","MGB-BP-3","Mgb-bp-3"],"crossReferences":{"drugbank":["DB12892"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2381408","canonicalSmiles":"CC(C)(C)C[C@@H]1N[C@@H](C(=O)N[C@H]2CC[C@H](O)CC2)[C@H](c2cccc(Cl)c2F)[C@]12C(=O)Nc1cc(Cl)ccc12","inchiKey":"IDKAKZRYYDCJDU-HBMMIIHUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SAR-405838","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MI-77301","SAR405838","Sar 405838","Sar-405838","Sar405838"],"crossReferences":{"drugbank":["DB12541"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL242080","canonicalSmiles":"CC(C)(C)c1cc(O)ccc1O","inchiKey":"BGNXCDMCOKJUMV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"E319","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["E319"],"crossReferences":{"PubChem":["104171088","144203557","144203558","144209507","144210401","17388706","17390000","26752804","4252498","50105455","71164"],"Wikipedia":["Tert-Butylhydroquinone"],"drugbank":["DB07726"],"chEBI":["78886"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL242948","canonicalSmiles":"NCCC(=O)N[C@@H](Cc1cnc[nH]1)C(=O)O","inchiKey":"CQOVPNPJLQNMDC-ZETCQYMHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"POLAPREZINC","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Carnosine","Polaprezinc","Z 103","Z-103"],"crossReferences":{"PubChem":["11113307","26754272"],"Wikipedia":["Carnosine"],"drugbank":["DB11695"],"chEBI":["15727"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL244342","canonicalSmiles":"CN(C(=O)CCN1Cc2cc(C(=O)c3ccccc3)ccc2N=C1N)C1CCCCC1","inchiKey":"KTRFBFMYAJOXLG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL244342","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08749"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL251429","canonicalSmiles":"Nc1nc(N)c2c(OCC3CCN(Cc4ccccc4F)CC3)cccc2n1","inchiKey":"GYKIQIOWVKCVBP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL251429","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["99367985"],"drugbank":["DB07642"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL272557","canonicalSmiles":"Nc1nc(=O)n([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2F)cc1I","inchiKey":"GIMSJJHKKXRFGV-BYPJNBLXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FIACITABINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fiac","Fiacitabine"],"crossReferences":{"PubChem":["170466497"],"drugbank":["DB12901"]},"childChemblIds":["CHEMBL3228488"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL298737","canonicalSmiles":"Cn1c(=O)c2nc(N)[nH]c2n(C)c1=O","inchiKey":"ZZESAIGPDOBLKZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL298737","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01778"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL29919","canonicalSmiles":"Nc1cnc(-c2cc(Cl)cc(Cl)c2Cl)c(N)n1","inchiKey":"NNXUYJFHOVCRSM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ELPETRIGINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Elpetrigine","JZP-4"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3039544","drugType":"Protein","blackBoxWarning":false,"name":"TECEMOTIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Stimuvax"],"synonyms":["BLP-25","BLP25","BP-1-148","EMD 531444","Emepepimut-s","LIPOPEPTIDE BLP-25","Tecemotide"],"count":8,"description":"Protein drug with a maximum clinical trial phase of III (across all indications) and has 8 investigational indications."}
{"id":"CHEMBL304784","canonicalSmiles":"CCCC[C@@H](C=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(C)=O","inchiKey":"FMYKJLXRRQTBOR-BZSNNMDCSA-N","drugType":"Protein","blackBoxWarning":false,"name":"CHEMBL304784","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["26755321","26755322"],"drugbank":["DB07558"],"chEBI":["2423"]},"description":"Protein drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3092562","canonicalSmiles":"Cc1nc(-c2cnn(C)c2-c2ccc(C(F)(F)F)cn2)c2c(N3CCC3)ncnn12","inchiKey":"CLGCHUKGBICQTE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PF-05180999","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PF-05180999","PF-999","Pf-05180999"],"crossReferences":{"drugbank":["DB14885"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL311498","canonicalSmiles":"Oc1cc(O)c2c(c1)O[C@H](c1ccc(O)c(O)c1)[C@@H](O)C2","inchiKey":"PFTAWBLQPZVEMU-DZGCQCFKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CIANIDANOL","yearOfFirstApproval":1977,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["Spain"," Germany"," France"," Switzerland"],"classes":["Hematological toxicity"],"year":1985},"tradeNames":[],"synonyms":["Cianidanol","Cianidol"],"crossReferences":{"PubChem":["11113249","26753531","50105958","69414","85231341","90341637"],"drugbank":["DB14086"],"chEBI":["15600"]},"childChemblIds":["CHEMBL1256783"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1977. It was withdrawn in Spain,  Germany,  France and  Switzerland initially in 1985 due to Hematological toxicity."}
{"id":"CHEMBL3187365","canonicalSmiles":"CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1","inchiKey":"VSWBSWWIRNCQIJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"ASENAPINE","yearOfFirstApproval":2009,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Secuado","Sycrest"],"synonyms":["Asenapine"],"crossReferences":{"DailyMed":["asenapine","asenapine%20maleate"],"PubChem":["124899263"],"chEBI":["71255"]},"childChemblIds":["CHEMBL3544974"],"count":1,"approvedIndications":["EFO_0005407"],"linkedTargets":{"rows":["ENSG00000149295","ENSG00000102468"],"count":2},"linkedDiseases":{"rows":["EFO_0000289","MONDO_0002009","EFO_0000677","EFO_0009963","EFO_0005407","EFO_0001358","EFO_0000692","EFO_0005411","HP_0000713"],"count":9},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2009 and is indicated for psychosis. This drug has a black box warning from the FDA."}
{"id":"CHEMBL3301576","drugType":"Unknown","blackBoxWarning":false,"name":"PEGPLERANIB SODIUM","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Fovista"],"synonyms":["E-01AJ","E-10030","E01AJ","E10030","Pegpleranib sodium","X-01E","X01E"],"count":2,"linkedTargets":{"rows":["ENSG00000100311"],"count":1},"linkedDiseases":{"rows":["Orphanet_892","EFO_0001365"],"count":2},"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3301596","canonicalSmiles":"Cl.N[C@@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21","inchiKey":"YKXHIERZIRLOLD-DFIJPDEKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DASOTRALINE HYDROCHLORIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL3301595","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dasotraline hydrochloride","SEP-225289 HCI"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3301672","canonicalSmiles":"CCCCCC/C=C\\CCCCCCCCCC(=O)N[C@H]1[C@H](OC[C@H]2O[C@H](OP(=O)([O-])[O-])[C@H](NC(=O)CC(=O)CCCCCCCCCCC)[C@@H](OCCCCCCCCCC)[C@@H]2O)O[C@H](COC)[C@@H](OP(=O)([O-])[O-])[C@@H]1OCC[C@@H](CCCCCCC)OC.[Na+].[Na+].[Na+].[Na+]","inchiKey":"FEMINZOAAWPBPP-RHMAUSBNSA-J","drugType":"Small molecule","blackBoxWarning":false,"name":"ERITORAN TETRASODIUM","maximumClinicalTrialPhase":3,"parentId":"CHEMBL501259","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["B-1287","B1287","E-5564","E5564","Eritoran sodium","Eritoran tetrasodium","Eritoran tetrasodium salt"],"crossReferences":{"chEBI":["46692"]},"count":2,"linkedTargets":{"rows":["ENSG00000154589","ENSG00000136869"],"count":2},"linkedDiseases":{"rows":["EFO_0000565","HP_0100806"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3348963","canonicalSmiles":"CCOC(=O)[C@@H](N)Cc1ccc(-c2cc(O[C@H](c3ccc(Cl)cc3-n3ccc(C)n3)C(F)(F)F)nc(N)n2)cc1.O=C(O)CNC(=O)c1ccccc1","inchiKey":"XSFPZBUIBYMVEA-CELUQASASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TELOTRISTAT ETIPRATE","yearOfFirstApproval":2017,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL2105695","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Xermelo"],"synonyms":["LX1032 HIPPURATE","LX1606 HIPPURATE","Telotristat etiprate"],"crossReferences":{"DailyMed":["telotristat%20etiprate"]},"count":1,"approvedIndications":["HP_0002014"],"linkedTargets":{"rows":["ENSG00000139287","ENSG00000129167"],"count":2},"linkedDiseases":{"rows":["HP_0002014"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2017 and is indicated for diarrhea."}
{"id":"CHEMBL350320","canonicalSmiles":"NC(=O)[C@@H](N)Cc1ccccc1","inchiKey":"OBSIQMZKFXFYLV-QMMMGPOBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENYLALANINE AMIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04029"],"chEBI":["21371"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3542376","canonicalSmiles":"N#C[C@@H]1C[C@@H]2C[C@@H]2N1[14C](=O)[14C@@H](N)C12CC3CC(CC(O)(C3)C1)C2","inchiKey":"QGJUIPDUBHWZPV-HERGMUBKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3542376","maximumClinicalTrialPhase":0,"parentId":"CHEMBL385517","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3544907","drugType":"Small molecule","blackBoxWarning":false,"name":"PICOPLATIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AMD-473","AMD473","NX 473","NX-473","Picoplatin","ZD-0473","ZD0473"],"count":10,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 10 investigational indications."}
{"id":"CHEMBL3544944","canonicalSmiles":"O=c1[nH]c(C2CCCN2)nc2c1oc1ccc(Cl)cc12","inchiKey":"JJWLXRKVUJDJKG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BMS-863233","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"childChemblIds":["CHEMBL3544943"],"linkedTargets":{"rows":["ENSG00000097046"],"count":1},"linkedDiseases":{"rows":["MONDO_0004111","MONDO_0024880"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL3544981","canonicalSmiles":"NCCCC[C@@H]1NC(=O)[C@H](CCC(=O)O)NC(=O)c2cc([N+](=O)[O-])ccc2OCC[C@@H](C(=O)NCC(=O)O)NC1=O","inchiKey":"DVJXNXPFYJIACK-ULQDDVLXSA-N","drugType":"Protein","blackBoxWarning":false,"name":"TAVILERMIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MIM-D3","Tavilermide"],"crossReferences":{"drugbank":["DB12441"]},"childChemblIds":["CHEMBL3545067"],"count":1,"description":"Protein drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL3545053","drugType":"Small molecule","blackBoxWarning":false,"name":"EMD-1204831","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Emd-1204831"],"count":1,"linkedTargets":{"rows":["ENSG00000105976"],"count":1},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3545143","drugType":"Small molecule","blackBoxWarning":false,"name":"SR-13668","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SR13668","Sr-13668"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545305","canonicalSmiles":"CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O","inchiKey":"WZTIQQBMSJTRBR-WYKNNRPVSA-N","drugType":"Protein","blackBoxWarning":false,"name":"CIBINETIDE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ARA 290","ARA-290","ARA290","Ara 290","Ara290","Cibinetide"],"crossReferences":{"drugbank":["DB13006"]},"count":1,"description":"Protein drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3545328","canonicalSmiles":"O=C(Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)C1CCCN1","inchiKey":"ISOCDPQFIXDIMS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"XL-019","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["XL019","Xl-019"],"count":4,"linkedTargets":{"rows":["ENSG00000096968"],"count":1},"linkedDiseases":{"rows":["EFO_0004251","MONDO_0044903","EFO_0002429","EFO_0000479"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL3545330","canonicalSmiles":"c1cnc(NCc2ccc(CNc3ncccn3)cc2)nc1","inchiKey":"PXZXYRKDDXKDTK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MSX-122","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Msx 122","Msx-122"],"crossReferences":{"drugbank":["DB12715"]},"count":1,"linkedTargets":{"rows":["ENSG00000121966"],"count":1},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3545427","drugType":"Small molecule","blackBoxWarning":false,"name":"CM-082","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cm-082"],"count":7,"linkedTargets":{"rows":["ENSG00000128052","ENSG00000157404","ENSG00000113721","ENSG00000122025"],"count":4},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0001056","MONDO_0000544","EFO_0001365","EFO_0000681","EFO_0000702","EFO_0003060","EFO_0000311"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL3586471","canonicalSmiles":"COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)[O-].[Na+]","inchiKey":"AIUYVPGHBMKGAC-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3586471","maximumClinicalTrialPhase":0,"parentId":"CHEMBL483158","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3695568","canonicalSmiles":"COCC(=O)Nc1cc(COc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc(C)cc3)c3ccccc23)ccn1","inchiKey":"RTDCVLCTBQDLBW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"JNJ-49095397","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["JNJ-49095397","Jnj-49095397","RV-568","RV568","Rv568"],"count":3,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3707275","drugType":"Gene","blackBoxWarning":false,"name":"VORETIGENE NEPARVOVEC","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AAV-2-HRPE65V2","AAV2-hRPE65v2","SPK-RPE65","Voretigene neparvovec"],"count":2,"linkedTargets":{"rows":["ENSG00000116745"],"count":1},"linkedDiseases":{"rows":["EFO_0003966","Orphanet_71862","Orphanet_65"],"count":3},"description":"Gene drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3707400","drugType":"Small molecule","blackBoxWarning":false,"name":"INDANTADOL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Chf3381","Indantadol","V3381"],"count":4,"linkedTargets":{"rows":["ENSG00000161509","ENSG00000273079","ENSG00000116032","ENSG00000183454","ENSG00000189221","ENSG00000105464","ENSG00000176884","ENSG00000198785"],"count":8},"linkedDiseases":{"rows":["EFO_0005762","EFO_1000783","HP_0012735","EFO_0003843"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL372227","canonicalSmiles":"O=C(O)c1sccc1S(=O)(=O)Nc1ccc(Cl)cc1","inchiKey":"YRWKEEDITQJPCZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL372227","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08573"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL375530","canonicalSmiles":"OC[C@H]1O[C@@H](n2cnc3cc(Cl)c(Cl)cc32)[C@H](O)[C@@H]1O","inchiKey":"XHSQDZXAVJRBMX-DDHJBXDOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DICHLORORIBOBENZIMIDAZOLE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["5,6-Dichlorobenzimidazole Riboside","Dichlororibobenzimidazole"],"crossReferences":{"PubChem":["56463021"],"Wikipedia":["5,6-Dichloro-1-beta-D-ribofuranosylbenzimidazole"],"drugbank":["DB08473"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3794409","canonicalSmiles":"C[C@@H](N)c1ccc(C(=O)Nc2ccnc3[nH]ccc23)cc1.Cl","inchiKey":"IILQESWQPZIAGP-HNCPQSOCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3794409","maximumClinicalTrialPhase":0,"parentId":"CHEMBL571948","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3989406","canonicalSmiles":"C[C@H](N[C@@H](CCc1ccccc1)C(=O)O)C(=O)N1CCC[C@H]1C(=O)O.O.O","inchiKey":"MZYVOFLIPYDBGD-MLZQUWKJSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"ENALAPRILAT","yearOfFirstApproval":1988,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL577","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Enalaprilat","Vasotec"],"synonyms":["Enalapril diacid dihydrate","Enalapril diacid dihydrate anhydrous","Enalaprilat","MK-422"],"crossReferences":{"DailyMed":["enalaprilat"]},"count":2,"linkedTargets":{"rows":["ENSG00000159640"],"count":1},"linkedDiseases":{"rows":["EFO_0001360","EFO_0000407","EFO_0000537"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1988 and has 2 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL3989887","canonicalSmiles":"C=CC[C@@H]1/C=C(\\C)C[C@H](C)C[C@H](OC)[C@H]2O[C@@](O)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@H](/C(C)=C/[C@@H]3CC[C@@H](O)[C@H](OC)C3)[C@H](C)[C@@H](O)CC1=O)[C@H](C)C[C@@H]2OC.O","inchiKey":"NWJQLQGQZSIBAF-MLAUYUEBSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"TACROLIMUS","yearOfFirstApproval":1994,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL269732","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Adoport","Advagraf","Astagraf xl","Capexion","Envarsus","Envarsus xr","Modigraf","Perixis","Prograf","Protopic","Tacni","Tacrolimus","Vivadex"],"synonyms":["FK 506","FR900506","Tacrolimus","Tacrolimus hydrate"],"count":2,"approvedIndications":["HP_0000964","EFO_0000540"],"linkedTargets":{"rows":["ENSG00000088832"],"count":1},"linkedDiseases":{"rows":["HP_0000964","EFO_0000540"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1994 and is indicated for eczema and immune system disease. This drug has a black box warning from the FDA."}
{"id":"CHEMBL3989933","canonicalSmiles":"N=C(N)NCCC[C@@H](N)C(=O)O.O=C(O)C[C@H]1CCc2c1[nH]c1ccc(OCc3ccc(C4CCCC4)c(C(F)(F)F)c3)cc21","inchiKey":"GVPVVOSNDUAUKM-YMQOIHNTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETRASIMOD ARGININE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL3358920","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["APD334 L-Arginine","Etrasimod arginine"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3989967","canonicalSmiles":"CNc1nc(-c2cccc(NC(=O)c3ccc(C(=O)OC)cc3)c2)c2cc(OC)c(OC)cc2n1","inchiKey":"BBTFKAOFCSOZMB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LOTAMILAST","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["E6005","Lotamilast","RVT-501"],"crossReferences":{"drugbank":["DB12776"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL399043","canonicalSmiles":"C=C/C(C)=C/[C@@]1(C)SC(=O)C(C)=C1O","inchiKey":"SYQNUQSGEWNWKV-XUIVZRPNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"THIOLACTOMYCIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(5R)-Thiolactomycin","(R)-(+)-Thiolactomycin","5R-Thiolactomycin","Thiolactomycin"],"crossReferences":{"PubChem":["50106765","50106766","90341102"],"drugbank":["DB04302"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4073443","canonicalSmiles":"Cc1cc(Nc2cc(N)ncn2)c(=O)n2c1C(=O)NC21CCCCC1","inchiKey":"HKTBYUWLRDZAJK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TOMIVOSERTIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["EFT-508","Eft 508","Eft508","Tomivosertib","eFT508"],"crossReferences":{"drugbank":["DB15219"]},"childChemblIds":["CHEMBL4298140"],"count":6,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL412309","canonicalSmiles":"CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2c-1nc1ccc(O)cc1c2[Si](C)(C)C(C)(C)C","inchiKey":"XUSKJHCMMWAAHV-SANMLTNESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AR-67","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AR67","Ar-67","DB 67","DB-67"],"crossReferences":{"PubChem":["582483"],"drugbank":["DB12384"]},"count":4,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL414157","canonicalSmiles":"CCCn1c(=O)c2nc(C34CCC(CCC(=O)O)(CC3)CC4)[nH]c2n(CCC)c1=O","inchiKey":"ZWTVVWUOTJRXKM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TONAPOFYLLINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BG-9928","BG9928","Tonapofylline"],"crossReferences":{"drugbank":["DB12569"]},"childChemblIds":["CHEMBL535165"],"count":4,"linkedTargets":{"rows":["ENSG00000163485"],"count":1},"linkedDiseases":{"rows":["HP_0000083","EFO_0003144","EFO_0001421","EFO_0000373"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL414883","canonicalSmiles":"C[C@@H]1C[C@H]2O[C@@H]2/C=C\\C=C\\C(=O)Cc2c(Cl)c(O)cc(O)c2C(=O)O1","inchiKey":"WYZWZEOGROVVHK-GTMNPGAYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RADICICOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Monorden","Radicicol"],"crossReferences":{"drugbank":["DB03758"],"chEBI":["556075"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4163691","canonicalSmiles":"C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C)CC4)cc3)nc3ccoc23)c1","inchiKey":"LZMJNVRJMFMYQS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"POSELTINIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["HM71224","LY3337641","Ly3337641","Poseltinib"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4296683","canonicalSmiles":"CCCCCCCCC/C=C/C=C/C(=O)NCC(=O)N[C@H]1[C@H]([C@@H](O)CO)O[C@H](Nc2ncnc3nc[nH]c23)[C@H](O)[C@@H]1O","inchiKey":"LQIPDFIUPOYMPR-BKYURJJWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL4296683","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB15215"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4297411","canonicalSmiles":"Nc1c2c(nc3c1CCCC3)CCCC2.O=C(O)CCC(=O)O","inchiKey":"SXNZJEKZKUJFLV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OCTAHYDROAMINOACRIDINE SUCCINATE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL263198","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Octahydroaminoacridine succinate","Octohydroaminoacridine succinate"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4297849","canonicalSmiles":"C[C@@H]1CN(c2nc(-n3ccc(OCCC4(C(F)(F)F)CC4)n3)ccc2C(=O)NS(=O)(=O)c2ccccc2)C(C)(C)C1","inchiKey":"IGEOJNMYRZUKIK-IBGZPJMESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BAMOCAFTOR","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bamocaftor","VX-659","VX659","Vx-659"],"crossReferences":{"drugbank":["DB15177"]},"childChemblIds":["CHEMBL4298159"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4297897","drugType":"Oligonucleotide","blackBoxWarning":false,"name":"RADAVIRSEN","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AVI-7100","Avi-7100","Radavirsen"],"count":1,"description":"Oligonucleotide drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297981","drugType":"Enzyme","blackBoxWarning":false,"name":"IMLIFIDASE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["HMED-IdeS","Hmed-ides","IdeS","Imlifidase"],"count":5,"description":"Enzyme drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL4297983","drugType":"Unknown","blackBoxWarning":false,"name":"GZD-824 DIMESYLATE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["D-824 DIMESYLATE","GZD-824 DIMESYLATE","Gzd-824 dimesylate","HQP-1351","HQP-1351 DIMESYLATE","HQP1351","HQP1351 DIMESYLATE","Hqp1351"],"count":2,"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4298044","drugType":"Unknown","blackBoxWarning":false,"name":"MINT-1526A","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MINT-1526A","MINT1526A","Mint 1526a","Mint-1526a","Mint1526a","RG-7594"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4298076","drugType":"Unknown","blackBoxWarning":false,"name":"BEVIFIMOD","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bevifimod","PRTX-100","Prtx-100"],"count":2,"description":"Unknown drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL44","canonicalSmiles":"O=c1c(-c2ccc(O)cc2)coc2cc(O)cc(O)c12","inchiKey":"TZBJGXHYKVUXJN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GENISTEIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Bonistein"],"synonyms":["BIO 300","BIO-300","FW-635I-2","Genistein","NPI-031L","NSC-36586","SIPI-807-1"],"crossReferences":{"PubChem":["104171167","11111233","11111234","11113921","124880228","124880229","144203712","144208626","144210902","162108258","170466848","17389520","26665855","26747156","26752075","26752076","50104732","50104733","50114251","50114252","85231066","90340706","93197"],"Wikipedia":["Genistein"],"drugbank":["DB01645"],"chEBI":["28088"]},"count":14,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 14 investigational indications."}
{"id":"CHEMBL441343","canonicalSmiles":"O=C(O)c1ccc(O)cc1","inchiKey":"FJKROLUGYXJWQN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PARABEN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Para-hydroxybenzoic acid","p-Hydroxybenzoic Acid","paraben"],"crossReferences":{"PubChem":["144209540","144213618"],"Wikipedia":["4-Hydroxybenzoic_acid"],"drugbank":["DB04242"],"chEBI":["30763"]},"childChemblIds":["CHEMBL1762656"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL445236","canonicalSmiles":"CC(=O)NC(=N)NCCC[C@@H]1NC(=O)[C@H](CCCC(=O)O)NC(=O)[C@H](Cc2c[nH]cn2)N2C(=O)[C@H](C[C@H]2O)NC(=O)[C@H]2CCCN2C1=O","inchiKey":"FOZYKTUSOWWQGR-KNPYFFGGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ARGADIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Argadin"],"crossReferences":{"Wikipedia":["Argadin"],"drugbank":["DB04350"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL452587","canonicalSmiles":"C[C@](O)(c1ccc(C(=O)N(C2CC2)[C@H]2CC[C@H](c3cccnc3)CC2)cc1)C(F)(F)F","inchiKey":"FLRYWTWLHWACRP-GRWTVWFQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL452587","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07619"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4594285","drugType":"Small molecule","blackBoxWarning":false,"name":"PADELIPORFIN POTASSIUM","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Padeliporfin di-potassium","Padeliporfin dipotassium","Padeliporfin potassium","Stakel","WST-11 DIPOTASSIUM","WST11 DIPOTASSIUM","WST11 POTASSIUM"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4594419","canonicalSmiles":"CC(=O)N[C@@H]1C[C@H](NC(C)(C)C)CC[C@@H]1N1CC[C@H](Nc2ncnc3cc(C(C)(C)C)nn23)C1=O","inchiKey":"CMVHFGNTABZQJU-HCXYKTFWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BMS-813160","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMS-813160","Bms-813160"],"count":4,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL461101","canonicalSmiles":"CC1=NN(c2ccc(C)c(C)c2)C(=O)/C1=N\\Nc1cccc(-c2cccc(C(=O)O)c2)c1O","inchiKey":"XDXWLKQMMKQXPV-QYQHSDTDSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"ELTROMBOPAG","yearOfFirstApproval":2008,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Revolade"],"synonyms":["Eltrombopag","SB497115"],"crossReferences":{"DailyMed":["eltrombopag%20olamine"],"Wikipedia":["Eltrombopag"],"drugbank":["DB06210"],"chEBI":["85010"]},"childChemblIds":["CHEMBL461805","CHEMBL461806","CHEMBL3989691"],"count":21,"approvedIndications":["MP_0001914"],"linkedTargets":{"rows":["ENSG00000117400"],"count":1},"linkedDiseases":{"rows":["EFO_0000198","EFO_0000616","Orphanet_84","EFO_0000637","EFO_0001642","EFO_0000222","HP_0001915","Orphanet_182050","HP_0001873","EFO_0004599","EFO_0000565","EFO_0001422","EFO_0007160","EFO_0004220","MP_0001914","EFO_0006926","Orphanet_906","EFO_0000095","EFO_0001421","EFO_0006927","EFO_0004272","EFO_0001378","EFO_0003047","MONDO_0002245"],"count":24},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2008 and is indicated for hemorrhage and has 20 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL471","canonicalSmiles":"CC(C)NCC(O)c1ccc(NS(C)(=O)=O)cc1","inchiKey":"ZBMZVLHSJCTVON-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"SOTALOL","yearOfFirstApproval":1992,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Betapace","C07AA07","MJ-1999","Sorine","Sotalol"],"crossReferences":{"DailyMed":["sotalol%20hydrochloride"],"PubChem":["144203812","26751989"],"Wikipedia":["Sotalol"],"drugbank":["DB00489"],"chEBI":["63622"]},"childChemblIds":["CHEMBL1700"],"count":7,"approvedIndications":["EFO_0000319"],"linkedTargets":{"rows":["ENSG00000055118","ENSG00000169252","ENSG00000043591"],"count":3},"linkedDiseases":{"rows":["EFO_0000275","EFO_0004269","EFO_0004287","EFO_0003144","EFO_0005306","EFO_0004278","EFO_0000612","EFO_0000319"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1992 and is indicated for cardiovascular disease and has 6 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL477","canonicalSmiles":"Nc1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O","inchiKey":"OIRDTQYFTABQOQ-KQYNXXCUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ADENOSINE","yearOfFirstApproval":1989,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Adenocard","Adenocor","Adenoscan","Adenosine"],"synonyms":["Adenosine","NSC-7652","SR 96225","SR-96225"],"crossReferences":{"DailyMed":["adenosine"],"PubChem":["144204442","170465447","26751564","50104175","855932","90341699"],"Wikipedia":["Adenosine"],"drugbank":["DB00640"],"chEBI":["16335"]},"count":17,"approvedIndications":["EFO_0009493","EFO_1001450","EFO_0000319"],"linkedTargets":{"rows":["ENSG00000282608","ENSG00000170425","ENSG00000128271","ENSG00000163485"],"count":4},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000275","EFO_0000318","EFO_0001645","EFO_0000556","EFO_0000319","EFO_1000637","EFO_0003843","EFO_0000311","EFO_0003913","EFO_0000537","MP_0001845","EFO_0009493","EFO_1001450","EFO_0008585","EFO_0000095","HP_0004755","EFO_1002000","EFO_0008583","EFO_0000612","EFO_1000882"],"count":21},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1989 and has 3 approved and 14 investigational indications."}
{"id":"CHEMBL483995","canonicalSmiles":"CCOc1cccc(-c2ccc(NC(=O)/C(C#N)=C(/C)O)cc2)c1","inchiKey":"RPILZQUCBKIPAZ-AQTBWJFISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL483995","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07561"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL52606","canonicalSmiles":"C=C[C@@]1(C)CC(=O)[C@@]2(O)[C@](C)(O1)[C@@H](OC(C)=O)[C@@H](O)[C@H]1C(C)(C)CC[C@H](O)[C@@]12C","inchiKey":"OHCQJHSOBUTRHG-KGGHGJDLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"COLFORSIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Boforsin","Colforsin","Forskolin","HL 362","L 75 1362B"],"crossReferences":{"PubChem":["144204491","144212716","170466094","26752068","29215035","47193715","56320676"],"Wikipedia":["Forskolin"],"drugbank":["DB02587"],"chEBI":["42471"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL539204","canonicalSmiles":"O=S(=O)(O)CCNCl","inchiKey":"NMMHHSLZJLPMEG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"N-Chlorotaurine","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["N-Chlorotaurine"],"crossReferences":{"drugbank":["DB06633"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL53950","canonicalSmiles":"O=P(O)(O)C(NC1CCCCCC1)P(=O)(O)O","inchiKey":"LWRDQHOZTAOILO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"INCADRONIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Incadronic acid"],"crossReferences":{"drugbank":["DB06255"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL562314","canonicalSmiles":"NC[C@H]1CN(c2c(-c3ccccc3)cnc3[nH]ncc23)CCO1","inchiKey":"YBRZCAKSBYWZTC-ZDUSSCGKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL562314","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08774"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL607712","canonicalSmiles":"O=C(O)C(=O)Cc1ccc(O)cc1","inchiKey":"KKADPXVIOXHVKN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"4-HYDROXYPHENYLPYRUVIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["4-Hydroxy-Phenylpyruvate","4-Hydroxyphenylpyruvate"],"crossReferences":{"Wikipedia":["4-Hydroxyphenylpyruvic_acid"],"drugbank":["DB07718"],"chEBI":["15999"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL712","canonicalSmiles":"COc1ccc(C2C(=O)c3ccccc3C2=O)cc1","inchiKey":"XRCFXMGQEVUZFC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ANISINDIONE","yearOfFirstApproval":1957,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Miradon"],"synonyms":["Anisindione"],"crossReferences":{"PubChem":["144204923","14729672","170465379","26748631","50086377"],"Wikipedia":["Anisindione"],"drugbank":["DB01125"],"chEBI":["133809"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1957."}
{"id":"CHEMBL71733","canonicalSmiles":"C[n+]1cccc(C(N)=O)c1","inchiKey":"LDHMAVIPBRSVRG-UHFFFAOYSA-O","drugType":"Small molecule","blackBoxWarning":false,"name":"TRIGONELLAMIDE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["1-mna","Tria-662","Trigonellamide"],"crossReferences":{"drugbank":["DB11710"],"chEBI":["16797"]},"childChemblIds":["CHEMBL1209652"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL8145","canonicalSmiles":"O=c1c(-c2ccc(O)cc2)coc2cc(O)ccc12","inchiKey":"ZQSIJRDFPHDXIC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DAIDZEIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Daidzein"],"crossReferences":{"PubChem":["11111095","11114077","124879927","124879929","124879930","124879932","124879933","144208642","144213952","17389519","174007201","26747166","26747167","26752188","26752189","46500432","50085965","50104845","50104846","50104847","50113497","50113498","50126369","85231010","90341229"],"Wikipedia":["Daidzein"],"drugbank":["DB13182"],"chEBI":["28197"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL856","canonicalSmiles":"CCC1(c2ccccc2)C(=O)NCNC1=O","inchiKey":"DQMZLTXERSFNPB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PRIMIDONE","yearOfFirstApproval":1954,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Lepsiral","Liskantin","Mysoline","Neurosyn","Primidone"],"synonyms":["NSC-41701","Primidone"],"crossReferences":{"DailyMed":["primidone"],"PubChem":["104171217","11111659","11112270","11113350","144203789","144209146","144213511","170464846","17389534","50104129","50126364","56324597","855864","90340844"],"Wikipedia":["Primidone"],"drugbank":["DB00794"],"chEBI":["8412"]},"count":2,"approvedIndications":["EFO_0000474"],"linkedTargets":{"rows":["ENSG00000185313","ENSG00000153253","ENSG00000163288","ENSG00000183873","ENSG00000136546","ENSG00000166206","ENSG00000144285","ENSG00000169432","ENSG00000145864","ENSG00000168356","ENSG00000136531","ENSG00000007314","ENSG00000196876"],"count":13},"linkedDiseases":{"rows":["EFO_0000474","EFO_0000712"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1954 and is indicated for epilepsy and has 1 investigational indication."}
{"id":"CHEMBL94809","canonicalSmiles":"CCCCCCCCCCCCCCCCS(=O)(=O)F","inchiKey":"QIVFMUVBIHIZAM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HEXADECANESULFONYL FLUORIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Hexadecanesulfonyl Fluoride","Palmitylsulfonyl Fluoride"],"crossReferences":{"drugbank":["DB02035"],"chEBI":["43275"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL967","canonicalSmiles":"CN1C(=O)C(O)N=C(c2ccccc2)c2cc(Cl)ccc21","inchiKey":"SEQDDYPDSLOBDC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"TEMAZEPAM","yearOfFirstApproval":1981,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Kentepam","Normison","Restoril","Temaz","Temazepam"],"synonyms":["NSC-246303","Temazepam","Temazepam civ","WY-3917"],"crossReferences":{"DailyMed":["temazepam"],"PubChem":["144205223","144207242","29215382"],"Wikipedia":["Temazepam"],"drugbank":["DB00231"],"chEBI":["9435"]},"count":6,"approvedIndications":["EFO_0004698"],"linkedTargets":{"rows":["ENSG00000022355","ENSG00000182256","ENSG00000011677","ENSG00000113327","ENSG00000163285","ENSG00000151834","ENSG00000186297"],"count":7},"linkedDiseases":{"rows":["MONDO_0002050","HP_0000726","EFO_0000341","EFO_0005230","EFO_0004698","EFO_0000692"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1981 and is indicated for insomnia and has 5 investigational indications. This drug has a black box warning from the FDA."}
